Baseline characteristics of the Korean genetic cohort of inherited cystic kidney disease

Baseline characteristics of the Korean genetic cohort of inherited cystic kidney disease

Background Identifying genetic mutations in individuals with inherited cystic kidney disease is necessary for precise treatment. We aimed to elucidate the genetic characteristics of cystic kidney disease in the Korean population. Methods We conducted a 3-year prospective, multicenter cohort study at...

Full description

Bibliographic Details
Main Authors:	Jeong Min Cho, Hayne Cho Park, Jin Woo Lee, Hyunjin Ryu, Yong Chul Kim, Curie Ahn, Kyu-Beck Lee, Yeong Hoon Kim, Seungyeup Han, Yaerim Kim, Eun Hui Bae, Hee Gyung Kang, Eujin Park, Kyungjo Jeong, Seoon Kang, Jungmin Choi, Kook-Hwan Oh, Yun Kyu Oh
Format:	Article
Language:	English
Published:	The Korean Society of Nephrology 2023-09-01
Series:	Kidney Research and Clinical Practice
Subjects:	autosomal dominant polycystic kidney clinical epidemiology cystic kidney disease epidemiology polycystic kidney diseases
Online Access:	http://krcp-ksn.org/upload/pdf/j-krcp-23-097.pdf

Similar Items

Clinical and genetic characteristics of Korean autosomal dominant polycystic kidney disease patients
by: Yun Kyu Oh, et al.
Published: (2021-07-01)

Femoral Neuropathy Secondary to Autosomal Dominant Polycystic Kidney Disease: A Case Report
by: Jeehyun Yoo, et al.
Published: (2018-06-01)

Urinary N-acetyl-β-D glucosaminidase as a surrogate marker for renal function in autosomal dominant polycystic kidney disease: 1 year prospective cohort study
by: Park Hayne, et al.
Published: (2012-08-01)

Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease
by: Yaerim Kim, et al.
Published: (2023-05-01)

Risk Factors for Neurocognitive Functioning in Children with Autosomal Recessive Polycystic Kidney Disease
by: Stephen R. Hooper
Published: (2017-05-01)

Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period
by: Hyuk Huh, et al.
Published: (2023-03-01)

The Pathophysiology of Inherited Renal Cystic Diseases
by: Matthew Satariano, et al.
Published: (2024-01-01)

The Natural Course of Total Kidney Volume in Patients with Autosomal Dominant Polycystic Kidney Disease undergoing Hemodialysis
by: Ye Na Kim, et al.
Published: (2021-12-01)

The Longitudinal Study of Liver Cysts in Patients With Autosomal Dominant Polycystic Kidney Disease and Polycystic Liver Disease
by: Ryo Matsuura, et al.
Published: (2017-01-01)

Healthcare resource consumption and cost of care among patients with polycystic kidney disease in Italy
by: Degli Esposti L, et al.
Published: (2017-04-01)

Results of kidney transplantation in patients with end-stage renal failure caused by autosomal dominant polycystic kidney disease
by: V. S. Daineko, et al.
Published: (2019-07-01)

Cystic Kidney Diseases From the Adult Nephrologist’s Point of View
by: Roman-Ulrich Müller, et al.
Published: (2018-03-01)

Are you ready to accompany autosomal dominant polycystic kidney disease patients in their treatment journey? Real practice for selecting rapid progressors and treatment with tolvaptan
by: Yeonsoon Jung, et al.
Published: (2023-06-01)

Real-Time High Resolution Melting Analysis-PCR for Assessment of Gene Mutations in Human Autosomal Dominant Polycystic Kidney Disease
by: Mohd Jas, Rusni
Published: (2011)

Tolvaptan for the Treatment of Enlarged Polycystic Liver Disease
by: Hiroki Mizuno, et al.
Published: (2017-07-01)

Incidental finding of autosomal dominant polycystic kidney disease in a 52-year-old man: a case report.
by: Muhammad S. Ahmadu, et al.
Published: (2021-11-01)

Mayo imaging classification is a good predictor of rapid progress among Korean patients with autosomal dominant polycystic kidney disease: results from the KNOW-CKD study
by: Hayne Cho Park, et al.
Published: (2022-07-01)

AUTOSOMAL – DOMINANT POLYCYSTIC KIDNEY DISEASE – A GLEAM OF HOPE?
by: V.V. Doretskyi, et al.
Published: (2014-01-01)

Endothelin 1 gene is not a major modifier of chronic kidney disease advancement among the autosomal dominant polycystic kidney disease patients
by: Annapareddy Shiva Nagendra Reddy, et al.
Published: (2016-01-01)

Urinary angiotensinogen level is associated with potassium homeostasis and clinical outcome in patients with polycystic kidney disease: a prospective cohort study
by: Hyoungnae Kim, et al.
Published: (2019-03-01)

Tratamiento quirúrgico de la enfermedad poliquística hepática autosómica dominante, serie de casos
by: Andrés Ayala, et al.

Heterozygosity analysis of polycystic kidney disease 1 gene microsatellite markers for linkage analysis of autosomal dominant polycystic kidney disease type 1 in the iranian population
by: Razieh Fatehi, et al.
Published: (2017-01-01)

Pain in Autosomal Dominant Polycystic Kidney Disease
by: Mariusz Niemczyk
Published: (2014-07-01)

Tolvaptan: a possible preemptive treatment option in children with autosomal dominant polycystic kidney disease?
by: Hee Sun Beak, et al.
Published: (2023-12-01)

Autosomal dominant polycystic kidney disease with ectopic unilateral multicystic kidney: a case report
by: Yaw Amoah, et al.
Published: (2024-01-01)

Short-Term Outcome of Isolated Kidney Transplantation in Children with Autosomal Recessive Polycystic Kidney Disease: A Case Series and Literature Review
by: Ratna Acharya, et al.
Published: (2023-12-01)

Short-Term Dapagliflozin Administration in Autosomal Dominant Polycystic Kidney Disease—A Retrospective Single-Arm Case Series Study
by: Fumiyuki Morioka, et al.
Published: (2023-10-01)

LAPAROSCOPIC NEPHRECTOMY IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
by: O. N. Reznik, et al.
Published: (2016-11-01)

Glucose and Lipid Metabolism Abnormalities among Patients with Autosomal Dominant Polycystic Kidney Disease
by: Magda Fliszkiewicz, et al.
Published: (2019-11-01)

Tuberous sclerosis associated with autosomal dominant polycystic kidney disease: Case report about of the TSC2/PKD1 contiguous gene syndrome
by: Rodolfo M. Queiroz, et al.
Published: (2016-12-01)

Management of Autosomal Dominant Polycystic Kidney Disease (ADPKD) During Pregnancy: Risks and Challenges
by: McBride L, et al.
Published: (2020-05-01)

The modifiers of chronic kidney disease in autosomal dominant polycystic kidney disease and the role of the endothelin-1
by: Einollahi Behzad, et al.
Published: (2016-01-01)

Unraveling the Complexity of Childhood Polycystic Kidney Disease: A Case Study of Three Sisters
by: Ivana Trutin, et al.
Published: (2023-10-01)

Autosomal Dominant Polycystic Kidney Disease: From Pathophysiology of Cystogenesis to Advances in the Treatment
by: Jana Reiterová, et al.
Published: (2022-03-01)

Clinical manifestations, imaging findings and laboratory abnormalities in 51 patients with autosomal dominant polycystic kidney disease: Experience at Tirupati, South India
by: K M Bhargav, et al.
Published: (2018-01-01)

Management of nephrolithiasis in autosomal dominant polycystic kidney disease - A single center experience
by: Ramen Baishya, et al.
Published: (2012-01-01)

The structure and incidence of infection in the cysts in patients with autosom al dominant polycystic kidney disease on the waiting list of kidney transplantation
by: V. S. Daineko, et al.
Published: (2018-09-01)

Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease
by: José Luis Gorriz, et al.
Published: (2021-03-01)

Expert-level segmentation using deep learning for volumetry of polycystic kidney and liver
by: Tae Young Shin, et al.
Published: (2020-11-01)

Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
by: Yeshwanter Radhakrishnan, et al.
Published: (2022-07-01)